Literature DB >> 10436791

Diabetes and the risk of pancreatic cancer.

L Gullo1.   

Abstract

AIMS: Diabetes occurs more frequently in patients with pancreatic cancer than in the general population, and it has repeatedly been claimed that it is a risk factor for this tumor. However in most of the studies on this subject the duration of diabetes before the diagnosis of pancreatic cancer was not ascertained. In an attempt to clarify the cause of the association between these two pathologic conditions and to determine whether diabetes is a risk factor for pancreatic cancer we recently studied this association in a large number of patients with pancreatic cancer.
METHODS: A total of 720 patients with newly diagnosed pancreatic cancer (415 men and 305 women; mean age 62.6 years, range 22 to 79 years) and 720 controls matched for sex, age, social class, and geographic region, were enrolled in the study. All subjects were interviewed personally and in detail about their clinical history. The diagnosis of diabetes was based on criteria recommended by the American Diabetes Association.
RESULTS: One hundred sixty-four patients with pancreatic cancer (22.8%) and 60 controls (8.3%) had diabetes. In the majority of the patients with pancreatic cancer (56.1%), diabetes was diagnosed either concomitantly with the cancer (in 40.2%), or within two years before the diagnosis of cancer (in 15.9%). The association between the two conditions was significant (odds ratio, 3.04; 95% confidence interval, 2.21 to 4.17). However, when only patients with diabetes of three or more years' duration were considered, the association was no longer significant (odds ratio, 1.43; 95% confidence interval, 0.98 to 2.07). All the patients with pancreatic cancer whose diabetes had been diagnosed before the cancer had non-insulin-dependent diabetes; all but one of the control patients with diabetes had the non-insulin-dependent form of the disease.
CONCLUSIONS: Diabetes in patients with pancreatic cancer is frequently of recent onset and is presumably caused by the tumor. Diabetes is not a risk factor for pancreatic cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10436791

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Recent developments in diagnosis of pancreatic cancer.

Authors:  Arjun S Takhar; Ponni Palaniappan; Rajpal Dhingsa; Dileep N Lobo
Journal:  BMJ       Date:  2004-09-18

3.  Alteration of the Langerhans islets in pancreatic cancer patients.

Authors:  B M Schmied; A B Ulrich; H Matsuzaki; C Li; H Friess; M W Böchler; A Andron-Sandberg; T E Adrian; P M Pour
Journal:  Int J Pancreatol       Date:  2000-12

4.  Identifying patients with suspected pancreatic cancer in primary care: derivation and validation of an algorithm.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2012-01       Impact factor: 5.386

5.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.

Authors:  René Hennig; Xian-Zhong Ding; Wei-Gang Tong; Matthias B Schneider; Jens Standop; Helmut Friess; Markus W Büchler; Parviz M Pour; Thomas E Adrian
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 6.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

7.  Type 2 diabetes mellitus and CA 19-9 levels.

Authors:  Oya Uygur-Bayramicli; Resat Dabak; Ekrem Orbay; Can Dolapcioglu; Mehmet Sargin; Gamze Kilicoglu; Yuksel Guleryuzlu; Alpaslan Mayadagli
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

8.  Is dynamic autocrine insulin signaling possible? A mathematical model predicts picomolar concentrations of extracellular monomeric insulin within human pancreatic islets.

Authors:  Minghu Wang; Jiaxu Li; Gareth E Lim; James D Johnson
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Pancreatic carcinoma in fibrocalcific pancreatic diabetes: An eastern India perspective.

Authors:  Partha Pratim Chakraborty; Deep Dutta; Kaushik Biswas; Triranjan Sanyal; Sujoy Ghosh; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2012-12

Review 10.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.